Propoxyphene hydrochloride MCQs With Answer offers B.Pharm students a focused review of this opioid analgesic’s pharmacology, metabolism, adverse effects, and clinical implications. This concise, keyword-rich introduction covers propoxyphene’s mechanism of action as a weak mu‑opioid agonist, hepatic metabolism to norpropoxyphene, renal excretion, and well‑known cardiotoxic risks that led to regulatory withdrawal. The MCQs emphasize pharmacokinetics, drug interactions, toxicity management, contraindications, and monitoring — essential topics for clinical pharmacy and drug safety. Clear, exam‑style questions help reinforce critical concepts and application. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which class of drug does propoxyphene hydrochloride belong to?
- Nonsteroidal anti‑inflammatory drug
- Opioid analgesic
- Local anesthetic
- Antidepressant
Correct Answer: Opioid analgesic
Q2. The primary clinical use of propoxyphene was for:
- Severe neuropathic pain
- Mild to moderate pain relief
- General anesthesia induction
- Antitussive therapy exclusively
Correct Answer: Mild to moderate pain relief
Q3. Propoxyphene’s analgesic effect is mainly mediated through:
- NMDA receptor antagonism
- Selective COX‑2 inhibition
- Weak mu‑opioid receptor agonism
- GABA potentiation
Correct Answer: Weak mu‑opioid receptor agonism
Q4. The major active metabolite of propoxyphene associated with toxicity is:
- Normeperidine
- Norfentanyl
- Norpropoxyphene
- Hydromorphone
Correct Answer: Norpropoxyphene
Q5. A notable safety concern with propoxyphene therapy is:
- Severe hepatotoxicity as the most common adverse effect
- Renal stone formation
- Cardiotoxicity and fatal arrhythmias
- Pancreatitis
Correct Answer: Cardiotoxicity and fatal arrhythmias
Q6. Why did many regulatory agencies withdraw propoxyphene from the market?
- Lack of analgesic efficacy compared with placebo
- High risk of QT prolongation and torsades de pointes
- Excessive gastrointestinal bleeding
- High potential for abuse similar to heroin
Correct Answer: High risk of QT prolongation and torsades de pointes
Q7. The metabolite norpropoxyphene is problematic because it:
- Is rapidly eliminated and inactive
- Has strong anticholinergic effects only
- Accumulates and prolongs cardiotoxic effects
- Only causes local allergic reactions
Correct Answer: Accumulates and prolongs cardiotoxic effects
Q8. In the event of propoxyphene‑induced respiratory depression, the recommended immediate pharmacologic antagonist is:
- Flumazenil
- Naloxone
- Physostigmine
- Atropine
Correct Answer: Naloxone
Q9. Which organ system is primarily responsible for propoxyphene metabolism?
- Renal tubular cells
- Hepatic (liver) enzymes
- Pulmonary endothelium
- Gastrointestinal mucosa
Correct Answer: Hepatic (liver) enzymes
Q10. Compared to morphine, propoxyphene’s analgesic potency is generally described as:
- Much more potent
- Approximately equal
- Less potent
- Ineffective as an analgesic
Correct Answer: Less potent
Q11. Which laboratory or monitoring test is most important when assessing propoxyphene cardiotoxicity risk?
- Liver function tests only
- Serum creatinine only
- Electrocardiogram (ECG)
- Serum amylase
Correct Answer: Electrocardiogram (ECG)
Q12. In patients with renal impairment, propoxyphene treatment is risky because:
- Renal failure increases hepatic metabolism
- Norpropoxyphene accumulates due to reduced excretion
- It causes nephrotic syndrome
- It is converted to a nephroprotective agent
Correct Answer: Norpropoxyphene accumulates due to reduced excretion
Q13. Which clinical feature is NOT typically associated with opioid overdose including propoxyphene?
- Miosis (pinpoint pupils)
- Respiratory depression
- Hyperreflexia and mydriasis
- Coma
Correct Answer: Hyperreflexia and mydriasis
Q14. Concomitant use of propoxyphene with benzodiazepines commonly causes:
- Reduced analgesia
- Enhanced CNS and respiratory depression
- Prevention of cardiotoxicity
- Improved renal clearance
Correct Answer: Enhanced CNS and respiratory depression
Q15. Which statement about propoxyphene pharmacokinetics is correct?
- It is not absorbed orally
- It undergoes hepatic metabolism to active metabolites
- It is excreted unchanged exclusively in bile
- It has no active metabolites
Correct Answer: It undergoes hepatic metabolism to active metabolites
Q16. Which symptom is most indicative of propoxyphene‑related cardiotoxicity?
- Bradyarrhythmias and conduction abnormalities
- Excessive lacrimation only
- Isolated rash without systemic signs
- Elevated blood glucose only
Correct Answer: Bradyarrhythmias and conduction abnormalities
Q17. Pregnant patients given propoxyphene may experience which neonatal consequence?
- Fetal analgesia and potential neonatal respiratory depression
- Enhanced fetal cardiac conduction stability
- Guaranteed prevention of preterm labor
- Neonatal hyperactivity without respiratory effects
Correct Answer: Fetal analgesia and potential neonatal respiratory depression
Q18. Which enzyme system is most likely involved in propoxyphene hepatic metabolism?
- CYP450 hepatic enzymes
- Monoamine oxidase only
- Renal dehydrogenases
- Cytochrome oxidase in mitochondria
Correct Answer: CYP450 hepatic enzymes
Q19. Which clinical population was identified as especially vulnerable to propoxyphene toxicity?
- Young healthy adults with no comorbidities
- Patients with preexisting cardiac conduction abnormalities
- Patients on high‑fiber diets
- Those with isolated skin conditions only
Correct Answer: Patients with preexisting cardiac conduction abnormalities
Q20. After reports of cardiotoxicity, the U.S. FDA action regarding propoxyphene in 2010 was to:
- Increase recommended dosing
- Require additional marketing studies only
- Request voluntary withdrawal from the U.S. market
- Approve it for pediatric use
Correct Answer: Request voluntary withdrawal from the U.S. market
Q21. Which adverse effect is commonly associated with opioid therapy including propoxyphene?
- Severe neutropenia as the primary effect
- Constipation and gastrointestinal hypomotility
- Progressive weight loss only
- Hyperthyroidism
Correct Answer: Constipation and gastrointestinal hypomotility
Q22. A pharmacist counseling a patient on propoxyphene should warn about:
- Avoiding driving and operating machinery due to sedation
- Sun exposure increasing potency
- High risk of immediate withdrawal after one dose
- Enhanced blood clotting
Correct Answer: Avoiding driving and operating machinery due to sedation
Q23. Which sign differentiates opioid intoxication from anticholinergic overdose?
- Dry skin and mydriasis indicate opioid overdose
- Pinpoint pupils indicate opioid overdose
- Hypersalivation indicates opioid overdose
- Hyperthermia indicates opioid overdose
Correct Answer: Pinpoint pupils indicate opioid overdose
Q24. In forensic toxicology, detection of norpropoxyphene suggests:
- Recent use of benzodiazepines only
- Propoxyphene exposure and potential accumulation
- Fentanyl administration
- Alcohol intoxication exclusively
Correct Answer: Propoxyphene exposure and potential accumulation
Q25. Which management step is vital in suspected propoxyphene cardiotoxicity?
- Immediate dialysis as first‑line treatment in all cases
- Continuous cardiac monitoring and specialist cardiology input
- Administration of high‑dose aspirin
- Immediate use of flumazenil
Correct Answer: Continuous cardiac monitoring and specialist cardiology input
Q26. Which statement about propoxyphene withdrawal and dependence is true?
- It causes no physical dependence
- It can cause typical opioid withdrawal symptoms after chronic use
- Dependence is prevented by co‑administration of NSAIDs
- Withdrawal is characterized by hyperpigmentation only
Correct Answer: It can cause typical opioid withdrawal symptoms after chronic use
Q27. Which drug interaction increases the risk of serotonin syndrome or additive effects when combined with propoxyphene?
- Concomitant use with SSRIs and certain MAO inhibitors
- Concurrent acetaminophen use only
- Simultaneous vitamin C supplementation
- Topical antifungal agents
Correct Answer: Concomitant use with SSRIs and certain MAO inhibitors
Q28. Which formulation route was propoxyphene commonly available in historically?
- Intravenous only
- Oral tablets and combination oral preparations
- Transdermal patch exclusively
- Inhalational aerosol
Correct Answer: Oral tablets and combination oral preparations
Q29. Which monitoring parameter is least relevant for a patient on propoxyphene therapy?
- ECG for conduction abnormalities
- Renal function tests for metabolite clearance
- Frequent pregnancy tests in non‑pregnant men
- Assessment of CNS depression and respiratory rate
Correct Answer: Frequent pregnancy tests in non‑pregnant men
Q30. Which adverse cardiac ECG change has been reported with propoxyphene and its metabolite?
- ST elevation localized to V1 only always
- Widened QRS and prolonged QT interval
- Peaked T waves solely due to hyperkalemia always
- Complete absence of P waves without QRS changes
Correct Answer: Widened QRS and prolonged QT interval
Q31. In overdose, norpropoxyphene contributes to toxicity by:
- Neutralizing the parent drug completely
- Prolonging central nervous system and cardiac effects
- Reducing the bioavailability of propoxyphene
- Exerting only peripheral analgesic effects
Correct Answer: Prolonging central nervous system and cardiac effects
Q32. Which population should generally avoid propoxyphene if alternatives are available?
- Patients with controlled seasonal allergies
- Patients with a history of cardiac arrhythmias or QT prolongation
- Young adults with no comorbidities
- Patients using topical antiseptics
Correct Answer: Patients with a history of cardiac arrhythmias or QT prolongation
Q33. What is a common noncardiac adverse effect of propoxyphene?
- Ototoxicity with permanent hearing loss
- Severe constipation and nausea
- Hyperglycemia requiring insulin
- Marked hair loss within hours
Correct Answer: Severe constipation and nausea
Q34. Which statement about propoxyphene dosing in elderly patients is correct?
- Elderly patients tolerate standard adult doses without adjustments
- Lower doses or avoidance are recommended due to increased sensitivity and metabolite accumulation
- Doses should be doubled to achieve analgesia
- Only intramuscular dosing is safe in the elderly
Correct Answer: Lower doses or avoidance are recommended due to increased sensitivity and metabolite accumulation
Q35. If a patient presents with suspected propoxyphene overdose, the most appropriate initial action is:
- Immediate discharge home with advice
- Assess airway, breathing, circulation and provide supportive care
- Administer oral activated charcoal after 24 hours only
- Perform elective surgery
Correct Answer: Assess airway, breathing, circulation and provide supportive care
Q36. Which statement best describes propoxyphene’s current global regulatory status?
- It is widely recommended as first‑line analgesic worldwide
- It has been restricted or withdrawn in many countries due to safety concerns
- It is approved for use in pediatrics in most countries
- It is available over the counter without restrictions
Correct Answer: It has been restricted or withdrawn in many countries due to safety concerns
Q37. Which clinical sign would most strongly prompt immediate ECG monitoring in a patient who took propoxyphene?
- Mild pruritus without systemic signs
- Dizziness, syncope, or palpitations
- Slight nasal congestion only
- Localized rash with no systemic symptoms
Correct Answer: Dizziness, syncope, or palpitations
Q38. In pharmacology exams, propoxyphene is often used as an example of an opioid with:
- High abuse liability but no systemic toxicity
- Low potency, active metabolites with long half‑life, and cardiotoxic risk
- Exclusive peripheral activity and no CNS effects
- Selective kappa agonism only
Correct Answer: Low potency, active metabolites with long half‑life, and cardiotoxic risk
Q39. Which intervention does NOT reliably reverse propoxyphene‑induced cardiotoxicity?
- Supportive cardiac care and antiarrhythmic strategies
- Immediate naloxone for respiratory depression
- Giving naloxone to reverse QT prolongation specifically
- Specialist cardiology management for arrhythmias
Correct Answer: Giving naloxone to reverse QT prolongation specifically
Q40. Which symptom cluster best describes chronic opioid side effects that may occur with propoxyphene?
- Constipation, sedation, tolerance, and dependence
- Increased appetite, hyperactivity, and insomnia
- Rash, alopecia, and joint hypermobility
- Hypersalivation, hyperreflexia, and polyuria
Correct Answer: Constipation, sedation, tolerance, and dependence
Q41. Which pharmacological property increases the risk of propoxyphene accumulation during chronic dosing?
- Rapid renal clearance without active metabolites
- Formation of long‑lived active metabolites like norpropoxyphene
- Exclusive exhalation through the lungs
- Complete inactivation in the gastrointestinal tract
Correct Answer: Formation of long‑lived active metabolites like norpropoxyphene
Q42. Which alternative analgesic is often considered safer than propoxyphene for mild to moderate pain?
- Aspirin or acetaminophen (paracetamol) and other safer opioids when needed
- High‑dose methadone as first choice for mild pain
- Intravenous propoxyphene as safer alternative
- Large‑dose barbiturates for chronic pain
Correct Answer: Aspirin or acetaminophen (paracetamol) and other safer opioids when needed
Q43. Pharmacovigilance reports highlighted which major risk related to propoxyphene use?
- Frequent allergic contact dermatitis only
- Fatal overdoses linked to cardiac arrhythmias
- Universal protection from stroke
- Immediate improvement of renal function
Correct Answer: Fatal overdoses linked to cardiac arrhythmias
Q44. When teaching B.Pharm students about propoxyphene, which point is essential to emphasize?
- Propoxyphene is safe in all patients without monitoring
- Understanding its metabolism to norpropoxyphene and cardiotoxic risk is crucial
- It has no drug interactions
- It is the most potent opioid available
Correct Answer: Understanding its metabolism to norpropoxyphene and cardiotoxic risk is crucial
Q45. Which statement about naloxone use in propoxyphene toxicity is correct?
- Naloxone reliably reverses propoxyphene cardiotoxicity
- Naloxone reverses opioid‑induced respiratory depression but not the cardiotoxic effects of metabolites
- Naloxone has no role in treating any complications of propoxyphene
- Naloxone should never be used with opioids
Correct Answer: Naloxone reverses opioid‑induced respiratory depression but not the cardiotoxic effects of metabolites
Q46. Educational MCQs on propoxyphene should test knowledge of which interdisciplinary topics?
- Only chemistry structure without clinical context
- Pharmacology, toxicology, pharmacokinetics, regulatory affairs, and clinical management
- Only marketing strategies of drug companies
- Only compounding techniques unrelated to safety
Correct Answer: Pharmacology, toxicology, pharmacokinetics, regulatory affairs, and clinical management
Q47. Which overdose treatment step may be considered for severe propoxyphene poisoning with life‑threatening arrhythmias?
- Immediate use of topical analgesics only
- Advanced cardiac life support and specialist cardiology interventions
- Oral antihistamines at home
- Delayed supportive care after 72 hours
Correct Answer: Advanced cardiac life support and specialist cardiology interventions
Q48. For exam preparation, which mnemonic or concept helps recall propoxyphene’s main risks?
- “RENAL” meaning only renal stones
- “CARDIO” to remember cardiotoxicity, accumulation of metabolite, and ECG monitoring
- “SKIN” for dermatologic focus only
- “SWEET” to recall sugar interactions
Correct Answer: “CARDIO” to remember cardiotoxicity, accumulation of metabolite, and ECG monitoring
Q49. Which research or regulatory activity followed widespread safety concerns about propoxyphene?
- Complete endorsement and expanded indications
- Post‑marketing safety reviews and market withdrawals in many countries
- Immediate approval for over‑the‑counter sales
- Promotion as a nutritional supplement
Correct Answer: Post‑marketing safety reviews and market withdrawals in many countries
Q50. A final key teaching point for B.Pharm students about propoxyphene is:
- Always prescribe propoxyphene as first‑line therapy
- Recognize that drug safety evaluation, active metabolites, and patient monitoring determine clinical use and regulatory status
- Ignore metabolite effects when assessing safety
- Replace all analgesics with propoxyphene by default
Correct Answer: Recognize that drug safety evaluation, active metabolites, and patient monitoring determine clinical use and regulatory status
